Literature DB >> 5960140

A model for the action of vinblastine in vivo.

F A Valeriote, W R Bruce, B E Meeker.   

Abstract

A model for the action of vinblastine (VLB) on cells multiplying exponentially in vivo with a generation time, T(G), has been derived. It is based on the assumption that cells attempting to pass through mitosis in the presence of VLB lose their proliferative capacity and that this lethal effect occurs only when the cells are exposed to a concentration of VLB which is above a critical value, C(k). The model leads to two predictions. First, that the percentage of cells surviving at any time after exposure to a dose, D, of VLB is 100% if D < D(k) and decreases to 0% after a time, T(G), following a dose D >/= D(k).2(T G/T1/2), where D(k) represents the dose of VLB required to produce the concentration C(k), and T(1/2) is the half-life of the VLB in vivo. Second, that the time, T(G), at which the percentage of cells surviving an exposure to VLB, at doses greater than D(k).2(U G/T1/2), decreases to zero should be equal to the generation time of the cells. Both of these predictions were confirmed experimentally which indicates that the model adequately explains the action of VLB in vivo.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5960140      PMCID: PMC1367805          DOI: 10.1016/S0006-3495(66)86646-8

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  7 in total

1.  DISSEMINATION AND GROWTH OF TRANSPLANTED ISOLOGOUS MURINE LYMPHOMA CELLS.

Authors:  W R BRUCE; B E MEEKER
Journal:  J Natl Cancer Inst       Date:  1964-05       Impact factor: 13.506

Review 2.  THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.

Authors:  I S JOHNSON; J G ARMSTRONG; M GORMAN; J P BURNETT
Journal:  Cancer Res       Date:  1963-09       Impact factor: 12.701

3.  THE RADIATION SENSITIVITY OF TRANSPLANTED LYMPHOMA CELLS AS DETERMINED BY THE SPLEEN COLONY METHOD.

Authors:  R S BUSH; W R BRUCE
Journal:  Radiat Res       Date:  1964-04       Impact factor: 2.841

4.  The stathmokinetic effect of vincaleukoblastine on normal bone marrow and leukemic cells.

Authors:  G CARDINALI; G CARDINALI; J BLAIR
Journal:  Cancer Res       Date:  1961-12       Impact factor: 12.701

5.  Generation time of HeLa cells determined from cine records.

Authors:  T C HSU
Journal:  Tex Rep Biol Med       Date:  1960

6.  Effects of vinblastine on the proliferative capacity of L cells and their progress through the division cycle.

Authors:  N Bruchovsky; A A Owen; A J Becker; J E Till
Journal:  Cancer Res       Date:  1965-09       Impact factor: 12.701

7.  An in vitro assay for growth-inhibiting activity of vinblastine.

Authors:  F A Valeriote; W R Bruce
Journal:  J Natl Cancer Inst       Date:  1965-11       Impact factor: 13.506

  7 in total
  7 in total

1.  5-day vinblastine infusion for pancreatic adenocarcinoma. A phase II Southwest Oncology Group study.

Authors:  J T Guy; T Fleming; T W Pollock; S E Rivkin; R P Pugh; H Saiers; H E Hynes; J F Boyd
Journal:  Invest New Drugs       Date:  1990-05       Impact factor: 3.850

2.  Vincristine infusion. A phase I study.

Authors:  W Weber; G A Nagel; E Nagel-Studer; R Albrecht
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  [Synchronization of Ehrlich ascites tumor cells and its importance in the use of an alkylating cytostatic agent].

Authors:  H O Klein; K J Lennartz; W Habicht; M Eder; R Gross
Journal:  Klin Wochenschr       Date:  1970-08-15

4.  Cellular kinetics, cell cycles and cell killing.

Authors:  G M Hahn
Journal:  Biophysik       Date:  1967

5.  Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: a Southwest Oncology Group study.

Authors:  J D Cowan; S Green; J Lucas; J K Weick; S P Balcerzak; S E Rivkin; C A Coltman; L H Baker
Journal:  Invest New Drugs       Date:  1988-09       Impact factor: 3.850

6.  The rate of division of antibody-forming cells during the early primary immune response.

Authors:  D A Rowley; F W Fitch; D E Mosier; S Solliday; L W Coppleson; B W Brown
Journal:  J Exp Med       Date:  1968-05-01       Impact factor: 14.307

7.  Distinct events in the immune response elicited by transferred marrow and thymus cells. I. Antigen requirements and priferation of thymic antigen-reactive cells.

Authors:  G M Shearer; G Cudkowicz
Journal:  J Exp Med       Date:  1969-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.